CEO Series, Helen Springford Rare Revolution, August 2020 An interview conducted by Rare Revolution (RR) to Helen Springford (HS). Exploring Helen's past, present and future, her aims for Illingworth Research in the coming years and advice to other embarking on a career in clinical research. caret-down caret-up caret-left caret-right RR: […]
In the Media
The impact of the COVID-19 pandemic on clinical trials has been well chronicled in recent months, with new and ongoing studies targeting a number of diseases, particularly chronic conditions, being hit hard by reductions in patient participation. This has shifted fundamental approaches in clinical operations, with some pharma sponsors turning to digital […]
Juliet Hulse at Illingworth Research Group explores the threat posed by Covid-19 on global rare disease clinical trial programmes, and the opportunities that may arise from this dynamic global situation.
In this article I am going to ignore the typical metrics that are cited, such as the importance of clinical trial data being entered into the database, time to market and the cost of patient exclusivity. Instead, I shall focus on the influence of developing a truly patient-focused clinical trial, […]
What we do know is across several weeks of fire-fighting to respond to the immediate situation, clinical trial sponsors have not yet got to thinking about what happens next. Clearly the current challenges are daunting. There’s a lot that needs to happen before we start thinking about patients travelling to […]
I recall writing my nursing degree dissertation 30 years ago on the “Passive Role of the Patient.” I was concentrating on diabetic patients in hospital undergoing treatment for reasons other than their diabetes. Management of their diabetes was taken away from them the moment they put on a gown and […]
The patient centricity movement has been inspired by the empowerment of patients and patient advocacy groups through the internet, social media and new technology. This has caused a paradigm shift in the clinical research industry with protocol developers now viewing mobile nursing as an almost essential ingredient to the success […]